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Abstract
Freeform fabrication provides an effective process tool to manufacture advanced tissue scaffolds 
with specific designed properties. Our research focuses on using a novel Precision Extrusion 
Deposition (PED) process technique to directly fabricate Polycaprolactone (PCL) and composite 
PCL/ Hydroxyapatite (HA) tissue scaffolds. The scaffold morphology and the mechanical 
properties were evaluated using SEM and mechanical testing. In vitro biological studies were 
conducted to investigate the cellular responses of the composite scaffolds. Results and 
characterizations demonstrate the viability of the PED process as well as the good mechanical 
property, structural integrity, controlled pore size, pore interconnectivity, and the biological 
compatibility of the fabricated scaffolds.  
1.  Introduction 
Three-dimensional scaffolds play important roles in scaffold guided tissue engineering 
because they provide critical functions as extra-cellular matrices onto which cells can attach, 
grow, and form new tissues. To design scaffolds for load bearing tissue replacement, researchers 
often needs to address multiple biological, mechanical and geometrical design constraints. With 
precise control of the scaffold external and internal geometry, porosity, pore size and 
interconnectivity, the needed structural integrity, strength, and transport properties, can be 
provided for and an ideal micro-environment for cell and tissue in-growth and healing [1-3]. 
Most available scaffold fabrication methods, such as solvent casting, fiber bonding, phase 
separation, gas induced foaming, and salt leaching, are either limited to producing scaffolds with 
simple geometry, or depend on in-direct casting method for scaffold fabrication [4, 5], therefore 
they are impractical for the manufacturing of scaffolds with complex structural architectures. To 
overcome this, solid freeform fabrication techniques, such as 3D Printing, Multi-phase Jet 
Solidification, and Fused Deposition Modeling (FDM) have been widely adopted for scaffold 
fabrication [6, 7]. 
The SFF technique offers a unique opportunity to study the influence of the micro-
architecture upon cell proliferation and ECM generation. Traditional scaffold fabrication 
methods result in structures of random internal architecture and have great variation from part to 
part. Due to the repeatability of the PED process, a more thorough investigation into the 
influence of the internal micro-architecture on cellular responses is available. Employing a 
computer-aided tissue engineering approach, with a novel precision extruding deposition process 
composite Polycaprolactone/ Hydroxyapatite scaffolds for bone tissue engineering applications 
were fabricated.
2. Precision Extrusion Deposition  
Previous research has focused on Fuse Deposition Modeling (FDM) for the fabrication of 
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ceramic components. It has been show that the main obstacle for FDM, in the application of new 
materials with specific characteristics often comes from the use of intermediate precursor 
filament[8]. Furthermore, during the extrusion phase, the frequent buckling failures cause 
interruption of the process (with the necessary cooling down and warming up of the liquefier) 
and necessitates frequent operator intervention [9]. Consequently, this problem prevents an 
automatic and continuous process diminishing the main advantage of a filament-based system. In 
addition, the backpressure encountered during deposition limits the powder volume fraction in 
the filament [10] reducing the possibility of higher particle loading. 
 The new system, called Precision Extrusion Deposition (PED) and consisting of a mini-
extruder mounted on a high-precision positioning system (see figure 1), operates using with bulk 
material in granulated form, which avoids most of the material preparation steps in a filament-
based system. This configuration opens up the opportunity for the use of a wider range of 
materials, making the PED a viable alternative manufacturing process for composite materials. 
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Figure 1: Schematic of mini-extruder in precision extrusion deposition system 
3. Generation of Scaffold Geometry 
The fabrication of scaffolds for tissue engineering by means of rapid prototyping has many 
advantages, one of which is the ability to create patient specific implants with a controlled 
internal design. Through the use of commercially available software packages such as MIMICS, 
tissue geometry can be extracted from CT or MRI data and reconstructed as a 3D model. The 
model is then refined to fit the overall macro-structural requirements of the implant, while the 
micro-structure is governed by the designed tool path of the individual 2-D “slices” of the model. 
The pore size (L) and porosity (?) are controlled by the material extrudate diameter, orientation 
and spacing as seen in Figure 2.   
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Figure 2: Schematic of strand layout and porosity calculation 
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The porosity can be calculated from the following equation:  
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4. Materials 
Hydroxyapatite (HA, Clarkson Chromatography Products Inc, South Williamsport, PA), a 
calcium phosphate ceramic, has been widely investigated for bone tissue engineering 
applications because of its chemical similarity to the mineral constituent of natural bone. It is 
both mechanically strong and osteoconductive. However, because of its brittle characteristic and 
material properties, it is often difficult to process. 
Polycaprolactone (PCL, Sigma Aldrich Inc, Milwaukee, Wisconsin) a biodegradable and 
biocompatible polymer was combined with the HA. PCL is a semi-crystalline aliphatic polymer 
that has a slower degradation rate than most biopolymers in its homo-polymeric form. It has a 
low glass transition temperature at -60ºC, a melting temperature at about 58ºC - 60ºC, and a high 
thermal stability. It has a high decomposition temperature Td of 350ºC. The mechanical 
properties of Bulk PCL (Mw = 44,000) with a tensile strength of 16MPa, tensile modulus of 
400MPa, flexural modulus of 500MPa, elongation at yield of 7.0%, and elongation at break of 
80% have been reported. The operational temperature of the system ranged from 85ºC - 110ºC, 
well below the decomposition point of PCL. A composite PCL/HA material would provide 
increased osteocondutivity and mechanical strength over scaffolds constructed of PCL alone.
5. Results of Scaffold Fabrication 
Hydroxyapatite powder, with particles ranging in size from 10-25 microns, was melt blended 
with PCL, with 25% HA by weight. Two sets of cylindrical scaffolds, measuring 20mm in 
diameter, were fabricated with 450 micron roads and porosities of 60% and 70% respectively.. 
The liquefier temperature was set to 90oC, and a .245 mm exit diameter nozzle was used.   Each 
layer was filled with the designed scaffold pattern of a 0/90 degree orientation to generate the 
porous structure.
5.1 Evaluation of Morphology, Mechanical and Biological properties
The scaffold service topography and architecture was evaluated using an Environmental 
Scanning Electron Microscope (FEI-Phillips XL30 ESEM-TMP).  
Figure 3: (a): PCL/HA Scaffold ; (b): PCL/HA backscatter image at 65x.  
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©: PCL/HA backscatter image at 34x 
The SEM images show uniform dispersion of HA particles with no visible areas of 
agglomeration. In addition, HA particles are seen protruding from the surface of the scaffold. 
The required architecture for tissue engineering scaffolds could be achieved at the micron scale 
level. The uniformity of the pores and the depositing roads shown demonstrate the applicability 
of using the PED process to fabricate composite scaffolds at micro-scale level.   
5.2 Mechanical Testing 
Compression tests were conducted on scaffolds of PCL and PCL/HA of a 25% concentration 
by weight of HA. Each sample is 20mm in diameter and 20mm in height. Scaffolds of 60% and 
70% porosity were tested where the internal pore structure is of the 0/90 pattern with pore sizes 
of 450 microns and 750 microns respectively, and the diameter of the extrudate is 450 microns. 
The tests were conducted on the MTS insight 40 mechanical, with a cross-head displacement 
speed of 2 mm/min. Stress-Strain data was computed from Load-Displacement measurements, 
and the compressive modulus was determined from the elastic region of the curve.  The stress-
strain curves derived form the testing data are plotted in Figure 4. The calculated compressive 
modulus from the stress-strain data are listed in Table 1.  
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Figure 4: Stress-Strain curve for PCL and composite PCL/HA scaffold 
Table 1: Calculated Compressive Modulus from Stress-Strain Data 
Material Porosity
Compressive
Modulus
(MPa)
PCL/HA 60% 84
PCL 60% 59
PCL/HA 70% 76
PCL 70% 30
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5.3 Biological Characterization 
An in vitro initial cell viability study was conducted on HA/PCL composite scaffolds. 
Osteoblast cells (7F2) were seeded onto cylindrical samples with 300 micro pores and a porosity 
of 65%, and left to incubate for 7 days. A live/dead and bizbenzamide assays were performed to 
determine the location an approximate number of living cells. In addition a flurometric assay, 
alamar blue, was used to determine cell proliferation over the 7 day period. Readings were taken 
at days 0, 3, 7 and 10. Figure 5(a) show cellular attachment covering the top surface after only 4 
days. The experiment indicated that the composite material was, biocompatible with positive cell 
attachment and proliferation on the entire top surface of the scaffold structure, as shown in 
Figure 2.
              (a): Live/Dead day 4       (b): Bizbenzamide (nuclear staining) day 7 
Figure 5:  Biological Assay 
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Figure 6: Cell Proliferation over 10 days 
6.  Conclusion 
The ability to fabricate scaffolds of composite biomaterials using the PED system has been 
demonstrated. Biological testing has show that the fabrication process has no adverse cytotoxic 
effect on the process PCL and HA biomaterials. However, success in scaffold guided tissue 
engineering requires a greater understanding of the cellular response to the constructed micro 
environment. PED has the advantage of high precision on the micro scale as well as repeatability 
not available using more traditional scaffold manufacturing methods.  
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